))
RNA sequencing in Alzheimers investigations
Manage episode 448806669 series 3485398
Sisällön tarjoaa ResearchPod. ResearchPod tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We humans share over 99% of our DNA with each other. This means personalised therapies for diseases such as cancer or neurodegenerative conditions have to be tailored to the most minute differences between us - or even between our own cells.
Professor Mark Ebbert of the Sanders-Brown Center on Aging at the University of Kentucky leads a lab focusing on isoforms of RNA - tiny, short lived molecules - that could open whole new avenues for detection, diagnosis, and treatments of otherwise incurable diseases.
Read the original research: https://doi.org/10.1101/2023.08.06.552162
Find more at The Ebbert Lab
440 jaksoa
Jaa
